A detailed history of Ubs Asset Management Americas Inc transactions in Certara, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 225,704 shares of CERT stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225,704
Previous 257,106 12.21%
Holding current value
$2.25 Million
Previous $3.56 Million 25.79%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.46 - $16.58 $328,464 - $520,645
-31,402 Reduced 12.21%
225,704 $2.64 Million
Q2 2024

Aug 13, 2024

BUY
$13.36 - $18.94 $1.3 Million - $1.84 Million
97,285 Added 60.87%
257,106 $3.56 Million
Q4 2023

Feb 14, 2024

SELL
$12.12 - $18.19 $8,520 - $12,787
-703 Reduced 0.44%
159,821 $2.81 Million
Q3 2023

Nov 13, 2023

BUY
$13.9 - $19.58 $416,749 - $587,047
29,982 Added 22.97%
160,524 $2.33 Million
Q1 2023

May 15, 2023

SELL
$15.9 - $24.72 $134,800 - $209,576
-8,478 Reduced 6.1%
130,542 $3.15 Million
Q4 2022

Feb 14, 2023

SELL
$10.7 - $17.84 $19,538 - $32,575
-1,826 Reduced 1.3%
139,020 $2.23 Million
Q3 2022

Nov 14, 2022

SELL
$12.84 - $24.13 $165,366 - $310,770
-12,879 Reduced 8.38%
140,846 $1.87 Million
Q2 2022

Aug 12, 2022

BUY
$16.75 - $22.54 $376,607 - $506,789
22,484 Added 17.13%
153,725 $3.3 Million
Q1 2022

May 16, 2022

BUY
$17.89 - $28.73 $133,781 - $214,842
7,478 Added 6.04%
131,241 $2.82 Million
Q4 2021

Feb 14, 2022

BUY
$26.1 - $45.21 $1.02 Million - $1.77 Million
39,198 Added 46.35%
123,763 $3.52 Million
Q3 2021

Nov 15, 2021

BUY
$24.46 - $38.41 $892,692 - $1.4 Million
36,496 Added 75.92%
84,565 $2.8 Million
Q2 2021

Aug 16, 2021

BUY
$24.79 - $33.31 $1.19 Million - $1.6 Million
48,069 New
48,069 $1.36 Million

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.59B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.